
|Articles|September 1, 2003
Suppemental Biologics License Application Fied for Etanercept Psoriasis Tx
New efficacy and safety data continue to impress
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Lebrikizumab Enters Late-Stage Testing for Nummular Eczema
2
Subgroup Analysis Demonstrates Efficacy of Roflumilast Cream for AD in Pediatric Patients With Diverse Skin Types
3
Beyond the Plaques: How Psoriasis Shapes Work, Relationships, and Social Health
4
Sun Pharma’s Cosibelimab-ipdl (UNLOXCYT) Enters US Market for Advanced CSCC
5


















